Celiprolol therapy for vascular Ehlers-Danlos syndrome.
Brooke
Benjamin S
BS
Department of Surgery, Johns Hopkins Hospital, Baltimore, MD 21287, USA. bbrooke1@jhmi.edu
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000784:Aortic Dissection / Q000209:etiology / Q000517:prevention & control; D017542:Aneurysm, Ruptured / Q000209:etiology / Q000517:prevention & control; D017272:Celiprolol / Q000627:therapeutic use*; D004535:Ehlers-Danlos Syndrome / Q000150:complications* / Q000235:genetics / Q000378:metabolism; D006801:Humans; D015398:Signal Transduction; D016212:Transforming Growth Factor beta / Q000235:genetics / Q000378:metabolism; D014652:Vascular Diseases / Q000209:etiology / Q000517:prevention & control*
D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D016212:Transforming Growth Factor beta; D017272:Celiprolol